Combination therapy of ecabet sodium and cimetidine compared with cimetidine alone for gastric ulcer: Prospective randomized multicenter study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 9, 2003, Pages 1029-1033

  Murata, Hiroaki ^a   Kawano, Sunao ^b   Tsuji, Shingo ^a   Kamada, Takenobu ^h   Matsuzawa, Yuuji ^h   Katsu, Kenichi ^c   Inoue, Kyouichi ^h   Kobayashi, Kenichi ^d   Mitsufuji, Syouji ^e   Bamba, Tadao ^h   Kawasaki, Hironaka ^f   Kajiyama, Gorou ^g   Umegaki, Eiji ^c   Inoue, Masanori ^g   Saito, Ichimonji ^h  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

^d KANAZAWA UNIVERSITY   (Japan)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f TOTTORI UNIVERSITY   (Japan)

^g HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^h Department of General Medicine Hiroshima University ^*

Author keywords

Cimetidine; Ecabet sodium; Gastric ulcer; Mucoprotective agent; Prospective randomized study

Indexed keywords

12 SULFODEHYDROABIETIC ACID; CIMETIDINE;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRINKING BEHAVIOR; DRUG POTENTIATION; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ULCER; TREATMENT OUTCOME; ULCER HEALING;

EID: 10744232381     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.03093.x     Document Type: Article

References (24)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 16: 1311-5.
2. Peterson WL. Helicobacter pylori and peptic ulcer disease. N. Engl. J. Med. 1991; 324: 1043-8.
3. Wolfe M, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N. Engl. J. Med. 1999; 340: 1888-99.
4. Sato N, Kawano S, Tsuji S, Ogihara T, Yamada S. Gastric blood flow in ulcer diseases. Scand. J. Gastroenterol. Suppl. 1995; 208: 14-20.
5. Tsuji S, Kawano S, Hayashi N et al. Simultaneous analysis of mucosal and submucosal hemodynamics using infrared electronic endoscopy: effects of intraluminal acid on ulcer scars. Endoscopy 1995; 27: 679-82.
6. Lam SK. Why do ulcers heal with sucralfate? Scand. J. Gastroenterol. Suppl. 1990; 173: 6-16.
7. Kishimoto M, Yanai H, Okazaki Y, Matsui H, Yoshida T, Okita K. Characteristics of gastric mucus in elderly patients with gastric ulcers. Hepatogastroenterology 2001; 48: 1594-8.
8. Kinoshita M, Kume E, Tamaki H. Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium. J. Pharmacol. Exp. Ther. 1995; 275: 494-501.
9. 2 generation induced by ecabet sodium, a novel gastroprotective agent. Dig. Dis. Sci. 1997; 42: 83-90.
10. Furukawa O, Kume E, Sugamoto S, Kawauchi S, Takeuchi K. Effect of ecabet disodium, a novel locally-acting antiulcer drug, on epithelial restitution following injury by hypertonic NaCl in bullfrog stomach in vitro. Digestion 2000; 62: 116-25.
11. Pearson JP, Roberts NB. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus. Clin. Sci. (Colch) 2001; 100: 411-7.
12. Kinoshita M, Endo M, Yasoshima A et al. Ecabet sodium, a novel locally-acting ant-ulcer agent, protects the integrity of the gastric gel layer from pepsin-induced disruption in the rat. Aliment Pharmacol. Ther. 1999; 13: 687-94.
13. Ichikawa T, Ishihara K, Hayashida H, Hiruma H, Saigenji K, Hotta K. Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa. Dig. Dis. Sci. 2000, 45: 606-13.
14. Kinoshita M, Yamasaki K, Kokusenya Y, Tamaki H. Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats. Comparison with sucralfate. Dig. Dis. Sci. 1995; 40: 661-7.
15. Kinoshita M, Noto T, Tamaki H. Effects of a combination of ecabet sodium and cimetidine on experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats. Biol. Pharm. Bull. 1995; 18: 223-6.
16. Houston LJ, Mills JG, Wood JR. Does co-prescription of sucralfate with ranitidine therapy enhance the healing of gastric ulcer? Am. J. Gastroenterol. 1993; 88: 675-9.
17. Arakawa T, Kobayashi K, Yoshikawa T, Tarnawski A. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Dig. Dis. Sci. 1998; 43: 5S-13S.
18. Higuchi K, Arakawa T, Nebiki H et al. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status. Dig. Dis. Sci. 1998; 43: 99S-106S.
19. Kawano S, Tanimura H, Sato N et al. Age-related change in human gastric mucosal energy metabolism. Scand. J. Gastroenterol. 1991; 26: 701-6.
20. Chow JY, Ma L, Zhu M, Cho CH. The potentiating actions of cigarette smoking on ethanol-induced gastric mucosal damage in rats. Gastroenterol. 1997; 113: 1188-97.
21. Masuda E, Kawano S, Nagano K et al. Effect of intravascular ethanol on modulation of gastric mucosal integrity: possible role of endothelin-1. Am. J. Physiol. 1992; 262: G785-90.
22. Okada M, Yao T, Fuchigami T, Imamura K, Omae T. Factors influencing the healing rate of gastric ulcer in hospitalized subjects. Gut 1984; 25: 881-5.
23. Ma L, Chew JY, Cho CH. Cigarette smoking delays ulcer healing: role of constitutive nitric oxide synthesis in rat stomach. Am. J. Physiol. 1999; 276: G238-48.
24. Battaglia G, Di Mario F, Piccoli A, Vianello F, Farinati F, Naccarato R. Clinical markers of slow healing and relapsing gastric ulcer. Gut 1987; 28: 210-5.